Trials / Completed
CompletedNCT04396015
Evaluating Cognitive and Functional Impairment in Alzheimer's Dementia With a Ketogenic Diet.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- University of Alberta · Academic / Other
- Sex
- All
- Age
- 50 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The present study is being done in a scientifically rigorous manner, using readily available MCT oil (refined from coconut oil) versus a placebo oil to assess any cognitive and functional benefits for AD patients.
Detailed description
The proposed study, is a randomized placebo controlled cross-over study for 6 months, with an open label extension for another 6 months designed to test the benefits and safety of MCT oil in patients with established AD. It will be the first study on MCT oil ever done with this design, and for this duration in AD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Bulletproof Brain Octane | Medium chain triglyceride oil (MCT) |
| DIETARY_SUPPLEMENT | Placebo | Placebo (olive) oil |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2019-01-01
- Completion
- 2019-03-01
- First posted
- 2020-05-20
- Last updated
- 2020-05-20
Source: ClinicalTrials.gov record NCT04396015. Inclusion in this directory is not an endorsement.